Evidence map›Paper›PMID 30593885›Full record

ArticleEuropean journal of medical genetics2019

Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.

Jean-Marc Retrouvey, Doaa Taqi, Faleh Tamimi, Didem Dagdeviren, Francis H Glorieux, Brendan Lee, Renna Hazboun, Deborah Krakow, V Reid Sutton, Members of the BBD Consortium

Open access · greenAbstract read
In one paragraph

Article in European journal of medical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 14 institutions in 2 countries.

Jean-Marc RetrouveyFaculty of Dentistry, McGill University, Montreal, Quebec, Canada. Electronic address: jean-marc.retrouvey@mcgill.ca.
Doaa TaqiFaculty of Dentistry, McGill University, Montreal, Quebec, Canada.
Faleh TamimiFaculty of Dentistry, McGill University, Montreal, Quebec, Canada.
Didem DagdevirenFaculty of Dentistry, McGill University, Montreal, Quebec, Canada.
Francis H GlorieuxShriners Hospital for Children and McGill University, Montreal, Quebec, Canada.
Brendan LeeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Renna HazbounUCLA School of Dentistry, Los Angeles, CA, USA.
Deborah KrakowDepartment of Orthopedic Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
V Reid SuttonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Members of the BBD Consortium
McGill University · CAMontreal Children's Hospital · CABaylor College of Medicine · USShriners Hospitals for Children - Chicago · USUniversity of Nebraska Medical Center · USAlfred I. duPont Hospital for Children · USChildren's National · USHospital for Special Surgery · USOregon Health & Science University · USOsteogenesis Imperfecta Foundation · USShriners Hospitals for Children - Tampa · USUniversity of California, Los Angeles · USUniversity of South Florida · USUniversity of Washington · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI MICHAEL SEID · 2019 to 2026
$51.2M
Project 3: 3D ImagingU54AR068069 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 2014 to 2026
$19.3M
NCATS NIH HHS U2C TR002818NCATS NIH HHS UL1 TR002369NIAMS NIH HHS U54 AR068069
6 · The paper itself

Abstract

Osteogenesis imperfecta (OI) type V is an ultrarare heritable bone disorder caused by the heterozygous c.-14C > T mutation in IFITM5. The oro-dental and craniofacial phenotype has not been described in detail, which we therefore undertook to evaluate in a multicenter study (Brittle Bone Disease Consortium). Fourteen individuals with OI type V (age 3-50 years; 10 females, 4 males) underwent dental and craniofacial assessment. None of the individuals had dentinogenesis imperfecta. Six of the 9 study participants (66%) for whom panoramic radiographs were obtained had at least one missing tooth (range 1-9). Class II molar occlusion was present in 8 (57%) of the 14 study participants. The facial profile was retrusive and lower face height was decreased in 8 (57%) individuals. Cephalometry, performed in three study participants, revealed a severely retrusive maxilla and mandible, and moderately to severly retroclined incisors in a 14-year old girl, a protrusive maxilla and a retrusive mandible in a 14-year old boy. Cone beam computed tomograpy scans were obtained from two study participants and demonstrated intervertebral disc calcification at the C2-C3 level in one individual. Our study observed that OI type V is associated with missing permanent teeth, especially permanent premolar, but not with dentinogenesis imperfecta. The pattern of craniofacial abnormalities in OI type V thus differs from that in other severe OI types, such as OI type III and IV, and could be described as a bimaxillary retrusive malocclusion with reduced lower face height and multiple missing teeth.

Indexed as

PhenotypeAdolescentAdultChildChild, PreschoolFemaleHumansMaleMiddle AgedOsteogenesis ImperfectaCraniofacialDentalFracturesIFITM5OligodontiaOsteogenesis imperfecta

Identifiers

PMID30593885
PMCPMC6594916
OpenAlexW2905999019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.